The global infection control market is
expected to reach USD 258.3 billion by 2025, according to a new report by Grand
View Research, Inc. The market is driven by rising concerns with respect to a
significant upsurge in hospital acquired infections globally. This is believed
to facilitate greater penetration of infection control products. An influx in
development of new biologics and subsequent demand for sterilized formulations
serve as key growth factors for the overall infection control market. The
healthcare organizations are focused on implementing strategies for early
recognition, reporting, isolation, and surveillance of disease episodes of
potential public health concern. In addition, increasing number intensive
training modules, for nurses and other medical staff, on infection prevention
and control is presumed to provide high potential for extensive usage of
infection control products over the coming years.
For instance, College of Nurses
of Ontario released guidelines concerning standard practices, that is focused
on maintaining hand hygiene to reduce contamination and spread of infection.
Furthermore, Centers for Disease Control and Prevention (CDC) has released
guidelines for disinfection and sterilization for efficient usage of infection
control products by healthcare personnel in wide array of healthcare settings
such as ambulatory care, home care, hospitals, and others. As a consequence of
the aforementioned factors, it is presumed that there will be significant
improvement in the overall penetration rate of infection prevention and control
products, which is also anticipated to fuel the market demand as well as the
revenue to unprecedented heights.
Browse full research report on Global
Infection Control Market: http://www.grandviewresearch.com/industry-analysis/infection-control-market
Further key findings from
the report suggest:
- In the type segment, services are predicted to observe exponential growth as a consequence of increasing presence of third-party reprocessors and outsourcing of sterilization as a result of associated cost efficiency
- In the end-use segment, hospitals accounted for substantial share in 2016, as a consequence of high clinical urgency to curb the growing incidence of hospital acquired infections
- North America captured a dominant share of the overall infection control market owing to extensive infection prevention activities being implemented in hospitals, medical device and pharmaceutical companies
- The market in Asia Pacific is projected to witness exponential growth during the forecast period as a result of increasing awareness pertaining to spread of infections within healthcare settings and measures for prevention
- The competitive environment is marked by companies adopting sustainability strategies such as geographical expansion and mergers & acquisitions resulting in significant growth in their market share
- For instance, in July 2016, the Getinge Group acquired 1stCall Mobility Ltd, a company specializing in supplying rental equipment. This acquisition was carried out as a part of the company’s expansion strategy
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global infection
control market on the basis of type, end use, and region:
Infection Control Type Outlook (Revenue, USD Billion,
2014 - 2025)
- Equipment
- Disinfectors
- Washers
- Flushes
- Endoscope Reprocessors
- Sterilization Equipment
- Heat Sterilization Equipment
- Low Temperature Sterilization Equipment
- Radiation Sterilization Equipment
- Filtration Sterilization Equipment
- Liquid Sterilization Equipment
- Others
- Services
- Contract Sterilization
- Ethylene Oxide Sterilization
- E-beam Sterilization
- Gamma Sterilization
- Others
- Infectious Waste Disposal
- Consumables
- Infectious Waste Disposal
- Disinfectants
- Sterilization Consumables
- Personal Protective Equipment
- Others
Infection Control End-use Outlook (Revenue, USD Billion,
2014 - 2025)
- Hospitals
- Medical Device Companies
- Clinical Laboratories
- Pharmaceutical Companies
- Others
Infection Control Regional Outlook (Revenue, USD Billion,
2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Mexico
- Brazil
- Middle East & Africa
- South Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting services.
To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment